More vaccine doses on the way? Johnson & Johnson ready to provide doses for 20M Americans by end of March
Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for over 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration.
The company for the first time on Monday gave some specificity into the number of doses it will have immediately available. The vaccine, unlike those from Pfizer and Moderna, only requires one dose, so 20 million doses would completely vaccinate 20 million people.
More to come tomorrow: The news comes as part of prepared remarks posted by the House Energy and Commerce Committee for a hearing tomorrow morning with several vaccine manufacturers.
Pfizer is also ramping up its supply. John Young, the company’s chief business officer, said in testimony posted by the committee that the company will be able to increase production to 13 million doses per week by the middle of March, up from 4 to 5 million per week at the beginning of February.